Profile data is unavailable for this security.
About the company
FunPep Co Ltd is a Japan-based company engaged in the research and development business for pharmaceuticals. The main business is to promote research and development of functional peptides, which are the results of research at the Graduate School of Medicine, Osaka University, and to put them into practical use in the business fields such as pharmaceuticals, cosmetics and medical devices. The business model defines its technical area as a functional peptide-based area and a related area that has synergies with it. The Research & Development pipeline is composed of research themes for antibody-inducing peptides and developed products. The Company is engaged in the sale of peptide active ingredients through cosmetic raw material trading companies or sales companies.
- Revenue in JPY (TTM)314.00k
- Net income in JPY-1.91bn
- Incorporated2013
- Employees15.00
- LocationFunPep Co Ltd3F, No.7 Mizuho Bldg., 5-8-4, SendagayaCHUO-KU 103-0023JapanJPN
- Phone+81 353154200
- Fax+81 353154203
- Websitehttps://www.funpep.co.jp/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| PhoenixBio Co Ltd | 1.51bn | -311.88m | 1.97bn | 69.00 | -- | 1.42 | -- | 1.30 | -78.53 | -78.53 | 372.28 | 339.41 | 0.6513 | 0.9529 | 6.96 | 21,877,380.00 | -13.46 | -4.25 | -16.43 | -5.57 | 75.84 | 67.17 | -20.66 | -7.19 | 2.91 | -- | 0.2067 | -- | -10.14 | 3.29 | -1,801.92 | -- | 1.08 | -- |
| Kringle Pharma Inc | 72.62m | -905.42m | 2.98bn | 17.00 | -- | 2.37 | -- | 40.98 | -130.95 | -130.95 | 10.48 | 170.57 | 0.032 | -- | 1.01 | 4,272,000.00 | -39.93 | -23.52 | -42.03 | -24.93 | -- | -- | -1,246.73 | -349.89 | 16.65 | -3,738.20 | 0.00 | -- | -9.77 | -31.17 | -21.13 | -- | -- | -- |
| Veritas In Silico Inc | 91.14m | -425.67m | 3.11bn | 19.00 | -- | 1.75 | -- | 34.17 | -65.62 | -65.62 | 14.05 | 274.99 | 0.0441 | -- | 6.11 | -- | -20.59 | -- | -21.32 | -- | -- | -- | -467.05 | -- | 18.35 | -- | -- | -- | -53.18 | -- | -80.03 | -- | -- | -- |
| NPT Co Ltd | 0.00 | -266.47m | 3.41bn | 7.00 | -- | 43.82 | -- | -- | -54.98 | -54.98 | 0.00 | 15.98 | 0.00 | -- | -- | 0.00 | -318.44 | -- | -439.04 | -- | -- | -- | -- | -- | -- | -2,152.88 | 0.00 | -- | -- | -- | -68.67 | -- | -- | -- |
| FunPep Co Ltd | 314.00k | -1.91bn | 3.98bn | 15.00 | -- | 2.72 | -- | 12,660.04 | -51.03 | -51.03 | 0.0083 | 36.09 | 0.0001 | -- | -- | -- | -75.09 | -37.74 | -92.91 | -41.17 | -- | -- | -608,766.90 | -4,142.72 | 3.71 | -- | -- | -- | -94.88 | -36.20 | -115.00 | -- | -- | -- |
| Human Metabolome Technologies Inc | 1.43bn | 207.06m | 4.12bn | 62.00 | 19.65 | -- | 27.54 | 2.88 | 35.42 | 35.42 | 248.83 | -- | 0.6237 | 10.29 | 4.91 | 23,060,290.00 | 9.03 | 10.54 | 10.98 | 13.59 | 60.48 | 66.65 | 14.48 | 17.24 | 5.13 | 391.35 | 0.0555 | 20.98 | 8.12 | 5.40 | 5.42 | -- | 33.68 | -- |
| Ribomic Inc | 0.00 | -1.05bn | 4.67bn | 25.00 | -- | 1.36 | -- | -- | -23.81 | -23.81 | 0.00 | 63.04 | 0.00 | -- | -- | 0.00 | -31.15 | -29.95 | -32.30 | -31.15 | -- | -- | -- | -2,725.95 | 25.20 | -- | 0.00 | -- | -- | -55.55 | 0.5173 | -- | -6.86 | -- |
| Modalis Therapeutics Corp | 0.00 | -2.06bn | 5.16bn | 14.00 | -- | 1.75 | -- | -- | -27.71 | -27.71 | 0.00 | 33.64 | 0.00 | -- | -- | 0.00 | -66.07 | -35.65 | -74.94 | -36.83 | -- | -- | -- | -1,981.18 | -- | -- | 0.0888 | -- | -- | -- | 44.90 | -- | -67.80 | -- |
| D.Western Therapeutics Institute Inc | 419.76m | -1.06bn | 5.75bn | 21.00 | -- | 3.85 | -- | 13.70 | -24.98 | -24.98 | 9.48 | 27.56 | 0.1921 | 0.4194 | 2.71 | 19,988,760.00 | -48.31 | -24.39 | -52.24 | -26.58 | 89.75 | 93.00 | -251.53 | -142.25 | 8.69 | -274.87 | 0.2606 | -- | 10.09 | -4.07 | -58.82 | -- | -- | -- |
| Carna Biosciences, Inc. | 579.06m | -2.17bn | 5.94bn | 63.00 | -- | 19.19 | -- | 10.25 | -113.62 | -113.62 | 30.30 | 16.16 | 0.2894 | 1.24 | 6.17 | -- | -108.53 | -37.21 | -120.28 | -41.98 | 67.03 | 86.49 | -375.00 | -118.28 | 6.08 | -75.55 | 0.6979 | -- | -8.99 | -12.57 | 0.3262 | -- | -33.02 | -- |
